ADAPTIVE BIOTECHNOLOGIES · held by 1 fund · data as of 2026-06-03
Sector
Healthcare
Industry
Diagnostics & Research
Market cap
$2.42B
Price
$15.77
12-mo
+56.30%
Held by
1 fund
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers produ…